Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
No standardized clinical trials exist
Spine 29 , 26682676 (2004)
GHK-Cu does not inhibit ghrelin, does not stimulate GLP-1 receptors, and does not meaningfully alter insulin sensitivity
To assess the half maximal inhibitory concentration (IC50) of FOXO4-DRI on the serum limitation-induced senescent fibroblast and the non-senescent control fibroblast, the fibroblast viability in the 2% FBS induced senescent fibroblast and 10% FBS cultured non-senescent control fibroblast with increasing concentrations of FOXO4-DRI was detected, and the cell viability curves were showed in Supplementary Fig
US$ 24.27
US$ 21.09
US$ 23.09
US$ 29.53
US$ 22.72
US$ 22.60
US$ 26.93
US$ 22.11
US$ 27.25
